Literature DB >> 22567181

Comparison of adenosine deaminase levels in serum and synovial fluid between patients with rheumatoid arthritis and osteoarthritis.

Zahra Zakeri, Shahrokh Izadi, Abassali Niazi, Zohre Bari, Soodabeh Zendeboodi, Mansoor Shakiba, Mohammadali Mashhadi, Behzad Narouie, Mohammad Ghasemi-Rad.   

Abstract

OBJECTIVES: Adenosine deaminase (ADA) is an enzyme being involved in purine metabolism and plays a significant role in the immune system. The aim of this study was to investigate the use of adenosine deaminase levels in differentiating between rheumatoid arthritis and osteoarthritis.
MATERIAL AND METHODS: Thirty patients with rheumatoid arthritis and 30 osteoarthritis patients enrolled the study. They were matched in sex and age. Using the ROC curve, we determined the optimal serum and synovial cutoff for rheumatoid effusion.
RESULTS: The results showed a statistically significant difference between ADA levels in joint effusion and serum of patients with rheumatoid arthritis and osteoarthritis (p<0.001). Synovial fluid cutoff value for diagnosing rheumatoid arthritis was 20 with a sensitivity of 90% and specificity of 80% and the serum cutoff value was 15 with a sensitivity of 93% and specificity of 53.3%. Area under ROC curve for synovial ADA, ESR and CRP co-linearity was 99%.
CONCLUSION: We concluded that synovial total ADA assay can be a sensitive and specific test, being suitable for rapid diagnosis of rheumatoid effusions.

Entities:  

Keywords:  Adenosine deaminase (ADA); enzyme; human; immune system; osteoarthritis; purine metabolism; rheumatoid arthritis; serum; synovial fluid

Year:  2012        PMID: 22567181      PMCID: PMC3342715     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  15 in total

1.  Purine catabolic enzymes in human synovial fluids.

Authors:  R L Wortmann; J A Veum; J W Rachow
Journal:  Adv Exp Med Biol       Date:  1989       Impact factor: 2.622

2.  Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis.

Authors:  R A Sari; S Taysi; O Yilmaz; N Bakan
Journal:  Clin Exp Rheumatol       Date:  2003 Jan-Feb       Impact factor: 4.473

3.  Role of adenosine deaminase in activation of macrophages.

Authors:  K Yagawa; J Okamura
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

4.  Correlations between matrix metalloproteinase-9 and adenosine deaminase isozymes in synovial fluid from patients with rheumatoid arthritis.

Authors:  S Iwaki-Egawa; H Matsuno
Journal:  J Rheumatol       Date:  2001-03       Impact factor: 4.666

5.  Sex differences in osteoarthritis of the knee. The role of obesity.

Authors:  M A Davis; W H Ettinger; J M Neuhaus; W W Hauck
Journal:  Am J Epidemiol       Date:  1988-05       Impact factor: 4.897

Review 6.  Rheumatoid arthritis.

Authors:  D M Lee; M E Weinblatt
Journal:  Lancet       Date:  2001-09-15       Impact factor: 79.321

7.  Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis.

Authors:  Kadir Yildirim; Saliha Karatay; Meltem Alkan Melikoglu; Gurhan Gureser; Mahir Ugur; Kazim Senel
Journal:  Ann Clin Lab Sci       Date:  2004       Impact factor: 1.256

8.  [Serum interleukin 6 (il-6A) concentration correlates with matrix metalloproteinases and their tissue inhibitors in rheumatoid arthritis].

Authors:  Piotr Adrian Klimiuk; Stanisław Sierakowski; Justyna Chwiećko
Journal:  Pol Arch Med Wewn       Date:  2003-02

9.  Human plasma adenosine deaminase 2 is secreted by activated monocytes.

Authors:  Sachiko Iwaki-Egawa; Takaya Yamamoto; Yasuhiro Watanabe
Journal:  Biol Chem       Date:  2006-03       Impact factor: 3.915

10.  Adenosine in inflammatory joint diseases.

Authors:  E S L Chan; P Fernandez; B N Cronstein
Journal:  Purinergic Signal       Date:  2007-01-03       Impact factor: 3.765

View more
  8 in total

Review 1.  Purinergic signalling in the musculoskeletal system.

Authors:  Geoffrey Burnstock; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2013-08-14       Impact factor: 3.765

Review 2.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

3.  Etanercept administration prevents the inflammatory response induced by carrageenan in the murine air pouch model.

Authors:  Rodrigo Antônio Mattei; Eduardo Monguilhott Dalmarco; Tânia Silvia Fröde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-08-09       Impact factor: 3.000

4.  Serum Adenosine Deaminase as Inflammatory Marker in Rheumatoid Arthritis.

Authors:  Kiranmayi S Vinapamula; Srinivasarao V L N Pemmaraju; Siddartha Kumar Bhattaram; Aparna R Bitla; Suchitra M Manohar
Journal:  J Clin Diagn Res       Date:  2015-09-01

Review 5.  Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers.

Authors:  Philip M Brown; Arthur G Pratt; John D Isaacs
Journal:  Nat Rev Rheumatol       Date:  2016-10-27       Impact factor: 20.543

6.  Serum Adenosine Deaminase Level is High But Not Related with Disease Activity Parameters in Patients with Rheumatoid Arthritis.

Authors:  Gülseren Demir; Pınar Borman; Figen Ayhan; Tuba Ozgün; Ferda Kaygısız; Gulsen Yilmez
Journal:  Open Rheumatol J       Date:  2014-09-12

7.  Sensitivity and specificity of adenosine deaminase in diagnosis of juvenile idiopathic arthritis.

Authors:  Mina Doudkani-Fard; Vahid Ziaee; Mohamad-Hassan Moradinejad; Mojtaba Sedaghat; Mohammad-Taghi Haghi-Ashtiani; Zahra Ahmadinejad
Journal:  Med J Islam Repub Iran       Date:  2014-10-15

8.  Repeated Electroacupuncture Persistently Elevates Adenosine and Ameliorates Collagen-Induced Arthritis in Rats.

Authors:  Tian-Shen Ye; Zhong-Heng Du; Zhi-Hui Li; Wen-Xia Xie; Ka-Te Huang; Yong Chen; Zhou-Yang Chen; Huan Hu; Jun-Lu Wang; Jian-Qiao Fang
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-31       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.